Wang DY, Wang JW, Wang YB, Wei Q, Qu JG, Hong T. Generation and immunogenicity of a recombinant replication-incompetent adenovirus expressing human rotavirus NSP4 protein.
Shijie Huaren Xiaohua Zazhi 2006;
14:858-862. [DOI:
10.11569/wcjd.v14.i9.858]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To investigate the efficacy of passive protection induced by the recombinant adeno-virus bearing human rotavirus NSP4 gene and to explore the clues for novel rotavirus vaccine development.
METHODS: Human rotavirus NSP4 protein was expressed in a recombinant adenovirus. AdEasy system was recruited to facilitate the preparation and the NSP4 gene was inserted into the early 1 region of the vector by homologous recombination in E.coli. The expression of NSP4 was confirmed by Western blotting. The resultant recombinant adenovirus rvAdEasyNSP4 was induced to mice by intranasal (i.n.) immunization. Specific IgG and IgA antibodies were detected in the murine serum. Murine pups born to the rvAdEasyNSP4 immunized dams were challenged with simian rotavirus SA11 strain orally 4 d after birth, and the induced diarrhea was graded.
RESULTS: The recombinant adenovirus rvAdEasyNSP4 showed typical morphology under electron microscope. The transcription of NSP4 specific mRNA by rvAdEasyNSP4 was confirmed with RT-PCR in infected 293 cells, and the expression of the NSP4 protein was verified by Western blotting. After immunization for three times, the positive rates of serum IgG antibody were 28.5%, 85.7% and 100%, respectively, while after the first immunization, the titer of serum IgG reached 1:1 000. After immunization, the positive rate of IgA antibody reached the level of 71.4%. Moderate protection was achieved after simian rotavirus SA11 strain challenged in murine pups.
CONCLUSION: NSP4 protein of human rotavirus strain can be expressed by a recombinant adenovirus vector and trigger effective immune response in mice, laying a solid foundation for the development of novel rotavirus genetic engineering vaccine.
Collapse